Sign in
Not yet taking people in NetherlandsPhase 4

Tests whether breathing extra oxygen changes blood flow in the heart and lungs

Tests extra oxygen breathing in adults with heart, lung or blood vessel conditions.

Key facts

Who runs it
Stichting Radboud universitair medisch centrum
Where
Nijmegen, NetherlandsSee the site
Registry title
The effect of Oxygen sUppleTion on vascular resistance and FLOW: the OUTFLOW study
Status
Not yet recruiting
Phase
Phase 4
People taking part
24 people, planned
Started
1 Oct 2024
Planned end
1 Oct 2025
Type of study
Interventional
Record updated
31 October 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who are already planned for a heart or lung pressure test or a coronary function test, and who have no blocked heart arteries. It studies how extra oxygen changes blood flow.

Age
18 years or older
Sex
All sexes can join.
Disease stage
Planned for a clinically indicated test for small-vessel heart problems, suspected pulmonary hypertension, or heart transplant or LVAD screening. No obstructive coronary artery disease (50% or less visible narrowing, or a negative FFR/iFR/RFR test).

Main reasons for not taking part

  • Estimated glomerular filtration rate below 30 ml/min
  • Known COPD GOLD IV
  • Known moderate or severe valve disease
  • Clinically indicated oxygen treatment
  • Pacemaker, active pregnancy or contrast allergy

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Subject ≥18 years of age
  • Subject planned for clinically indicated: 1. CFT demonstrating microvascular dysfunction; or 2. RHC (and LHC) for suspected PH; or 3. RHC (and LHC) as a part of HTx or LVAD screening
  • No obstructive coronary artery disease (defined as ≤50% visual stenosis and/or negative FFR/iFR/RFR)
  • Able and willing to provide informed consent

Who cannot take part

  • Clinically indicated treatment with oxygen
  • Known history of chronic obstructive pulmonary disease GOLD IV
  • Known moderate and severe valvular disease
  • Contrast allergy
  • Complications during clinically indicated invasive heart catheterization
  • Estimated glomerular filtration rate of <30ml/min
  • Pacemaker in situ
  • Active pregnancy

Where in Netherlands

  • Stichting Radboud Universitair Medisch CentrumNijmegen, NetherlandsNot yet recruiting

About the trial

What the trial wants to find out

To objectify the effect of high-concentration (100%) oxygen suppletion on coronary, pulmonary and systemic haemodynamics, and the chronological sequence of these effects

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Official title
The effect of Oxygen sUppleTion on vascular resistance and FLOW: the OUTFLOW study
Plain-language title
Tests whether breathing extra oxygen changes blood flow in the heart and lungsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
31 October 2024